You are here: Industry Insights > oral suspension

News List

Novartis Issues Recall of Promacta® 12.5 mg for Oral Suspension americanpharmaceuticalreview
May 16, 2019
Novartis has announced a voluntary recall of three lots of Promacta (eltrombopag) 12.5 mg for oral suspension to the consumer level.
Dr. Reddy's Announces Launch of Sevelamer Carbonate in the U.S. Market americanpharmaceuticalreview
December 29, 2018
Dr. Reddy’s Laboratories announced the launch of Sevelamer Carbonate for Oral Suspension, in 0.8 g and 2.4 g packets, a therapeutic equivalent generic version of ......
Tris Pharma Issues Recall of Infants' Ibuprofen Concentrated Oral Suspension americanpharmaceuticalreview
December 06, 2018
Tris Pharma, Inc. has voluntarily recalled three (3) lots of Infants' Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, to the retail level.....
FDA Approves Tiglutik Oral Suspension americanpharmaceuticalreview
September 07, 2018
ITF Pharma announced the U.S. Food and Drug Administration (FDA) has approved Tiglutik (riluzole) oral suspension for the treatment of amyotrophic lateral sclerosis (ALS).